OPT
Opthea Limited - ADR

229
Mkt Cap
$6.5M
Volume
1,684.00
52W High
$3.41
52W Low
$0.0059
PE Ratio
0.03
OPT Fundamentals
Price
$0.038
Prev Close
$0.0251
Open
$0.0468
50D MA
$0.0257
Beta
4.49
Avg. Volume
8,789.95
EPS (Annual)
-$1.06
P/B
0.29
$688.84
Loading...
Loading...
News
all
press releases
News Placeholder
Opthea (NASDAQ:OPT) Stock Price Up 7.2% - Here's What Happened
Opthea (NASDAQ:OPT) Trading 7.2% Higher - Still a Buy...
MarketBeat·4mo ago
News Placeholder
Opthea raises solvency concerns after phase 3 trial fails
Investing.com--U.S. and Australia-listed biopharmaceutical firm Opthea Ltd (NASDAQ:OPT) on Monday raised concerns over its ability to continue operations after a major phase 3 trial did not meet its primary endpoint.
investing.com·1y ago
<
...
1
>

Latest OPT News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.